For: | Grizzi F, Franceschini B, Chiriva-Internati M, Liu Y, Hermonat PL, Dioguardi N. Mast cells and human hepatocellular carcinoma. World J Gastroenterol 2003; 9(7): 1469-1473 [PMID: 12854143 DOI: 10.3748/wjg.v9.i7.1469] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i7/1469.htm |
Number | Citing Articles |
1 |
Gopalakrishnan Ramakrishnan, Sundaram Jagan, Sattu Kamaraj, Pandi Anandakumar, Thiruvengadam Devaki. Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis. Investigational New Drugs 2009; 27(3): 233 doi: 10.1007/s10637-008-9163-y
|
2 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 121 doi: 10.1007/978-3-319-26956-6_5
|
3 |
Gokuladhas Krishnan, Jayakumar Subramaniyan, Pramila Chengalvarayan Subramani, Barath Muralidharan, Devaki Thiruvengadam. Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats. Asian Journal of Pharmaceutical Sciences 2017; 12(5): 442 doi: 10.1016/j.ajps.2017.04.001
|
4 |
Jacek Baj, Magdalena Kołodziej, Joanna Kobak, Jacek Januszewski, Kinga Syty, Piero Portincasa, Alicja Forma. Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma—From Inflammation to Hepatocellular Carcinoma Progression. International Journal of Molecular Sciences 2024; 25(19): 10233 doi: 10.3390/ijms251910233
|
5 |
Nisha Susan Thomas, Kiran George, Sivaranjani Arivalagan, Vijay Mani, Aktarul Islam Siddique, Nalini Namasivayam. The in vivo antineoplastic and therapeutic efficacy of troxerutin on rat preneoplastic liver: biochemical, histological and cellular aspects. European Journal of Nutrition 2017; 56(7): 2353 doi: 10.1007/s00394-016-1275-0
|
6 |
B. Franceschini, C. Russo, N. Dioguardi, F. Grizzi. Increased liver mast cell recruitment in patients with chronic C virus‐related hepatitis and histologically documented steatosis. Journal of Viral Hepatitis 2007; 14(8): 549 doi: 10.1111/j.1365-2893.2007.00859.x
|
7 |
Min‐Jie Ju, Shuang‐Jian Qiu, Qiang Gao, Jia Fan, Ming‐Yan Cai, Yi‐Wei Li, Zhao‐You Tang. Combination of peritumoral mast cells and T‐regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Science 2009; 100(7): 1267 doi: 10.1111/j.1349-7006.2009.01182.x
|
8 |
K. Balamurugan, J. Karthikeyan. Evaluation of the antioxidant and anti-inflammatory nature of luteolin in experimentally induced hepatocellular carcinoma. Biomedicine & Preventive Nutrition 2012; 2(2): 86 doi: 10.1016/j.bionut.2012.01.002
|
9 |
Hao Zhang, Lin Sun, Xiao Hu, Alessandro Granito. Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/4614257
|
10 |
Fabio Grizzi, Giuseppe Di Caro, Luigi Laghi, Paul Hermonat, Paolo Mazzola, Diane D Nguyen, Saba Radhi, Jose A Figueroa, Everardo Cobos, Giorgio Annoni, Maurizio Chiriva-Internati. Mast cells and the liver aging process. Immunity & Ageing 2013; 10(1) doi: 10.1186/1742-4933-10-9
|
11 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 1469 doi: 10.1007/978-3-319-26956-6_83
|
12 |
Asami Hagiwara, Yoshiyasu Nakamura, Rumi Nishimoto, Satoko Ueno, Yohei Miyagi. Induction of tryptophan hydroxylase in the liver of s.c. tumor model of prostate cancer. Cancer Science 2020; 111(4): 1218 doi: 10.1111/cas.14333
|
13 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_83-1
|
14 |
Domenico Ribatti, Roberto Tamma, Enrico Crivellato. The dual role of mast cells in tumor fate. Cancer Letters 2018; 433: 252 doi: 10.1016/j.canlet.2018.07.005
|
15 |
Barbara Franceschini, Giorgia Ceva-Grimaldi, Carlo Russo, Nicola Dioguardi, Fabio Grizzi. The Complex Functions of Mast Cells in Chronic Human Liver Diseases. Digestive Diseases and Sciences 2006; 51(12): 2248 doi: 10.1007/s10620-006-9082-8
|
16 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_185-1
|
17 |
Nisha Susan Thomas, Kiran George, Athavan Alias Anand Selvam. Troxerutin subdues hepatic tumorigenesisviadisrupting the MDM2–p53 interaction. Food & Function 2018; 9(10): 5336 doi: 10.1039/C8FO01111G
|
18 |
Shi-Yun Tan, Yan Fan, He-Sheng Luo, Zhi-Xiang Shen, Yi Guo, Liang-Jia Zhao. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World Journal of Gastroenterology 2005; 11(8): 1210-1214 doi: 10.3748/wjg.v11.i8.1210
|
19 |
Xiaoqiang Gao, Shi Zuo. Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells. Clinical and Experimental Medicine 2023; 23(6): 1881 doi: 10.1007/s10238-023-01015-2
|
20 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_5-1
|
21 |
Giovanni Paolino, Paola Corsetti, Elisa Moliterni, Serena Corsetti, Dario Didona, Marcello Albanesi, Carlo Mattozzi, Paolo Lido, Stefano Calvieri. Mast cells and cancer. Giornale Italiano di Dermatologia e Venereologia 2019; 154(6) doi: 10.23736/S0392-0488.17.05818-7
|
22 |
Carlo Masserdotti, Michele Drigo. Retrospective study of cytologic features of well‐differentiated hepatocellular carcinoma in dogs. Veterinary Clinical Pathology 2012; 41(3): 382 doi: 10.1111/j.1939-165X.2012.00436.x
|
23 |
Jeffrey To, Soumita Ghosh, Xun Zhao, Elisa Pasini, Sandra Fischer, Gonzalo Sapisochin, Anand Ghanekar, Elmar Jaeckel, Mamatha Bhat. Deep learning-based pathway-centric approach to characterize recurrent hepatocellular carcinoma after liver transplantation. Human Genomics 2024; 18(1) doi: 10.1186/s40246-024-00624-6
|
24 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3409 doi: 10.1007/978-3-319-26956-6_185
|
25 |
Fangshun Tan, Zhuoying Du, Juanjuan Zhong, Yinxin Wu, Jie Mou, Fangnan Zhao, Yuling Liu, Jinlan Chen, Zihan Liang, Yunxi Zhou, Wanling Lv, Yuxuan Cai, Bei Wang, Wen Xu, Chengfu Yuan. Application of Nanomedicine in Tumor Targeting Inflammatory
Pathway. Current Medicinal Chemistry 2025; 32(12): 2291 doi: 10.2174/0109298673277325231229093344
|
26 |
Veronica Jarido, Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Joanne Thomson, Kristen Stephenson, Heather Francis. The emerging role of mast cells in liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 313(2): G89 doi: 10.1152/ajpgi.00333.2016
|
27 |
Carlo Masserdotti. Proportion of mast cells in normal canine hepatic cytologic specimens: comparison of 2 staining methods. Veterinary Clinical Pathology 2013; 42(4): 522 doi: 10.1111/vcp.12086
|